Biostatistics for Lawyers

30 Sep , 2021

To register for the upcoming live webinar, please Click Here

The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.

To register for the upcoming live webinar, please Click Here

More Webcasts

Federal Contractor B...

As the largest purchaser of goods and services in the world, the United States Government requires f...

There’s a Reporter...

You’ve arranged to speak with a reporter. Do you know how to deliver insights that are memorab...

Defense Strategies f...

Class action waivers in arbitration agreements remain enforceable, but a decade of U.S. Supreme Cour...

Arbitration or Trial...

This program examines the scope, jurisdiction, and exceptions to the Federal Arbitration Act (FAA), ...

Grand Jury Proceedin...

The bar that grand jury targets face in challenging a grand jury subpoena or seeking access to a gra...

Napkin Litigation Fr...

Business disputes involving closely held companies, partnerships, shareholders, and informal busines...

How To Win Bid Prote...

During this course you will take a deep dive into federal bid protest litigation at the U.S. Court o...

Federal Titling, Ind...

This course analyzes federal titling and indexing requirements and how to expunge or amend your reco...

Modern Cross-Examina...

Attendees will learn how to effectively cross-examine witnesses at trial.  The conventional wis...

Year in Review – K...

2026 was a very important year when it comes to federal procurement developments, Artificial Intelli...